BRIEF published on 06/30/2026 at 02:05, 27 days 18 hours ago Analyse financière de MedMira pour le troisième trimestre de l'exercice 2026 et efforts d'expansion sur le marché Résultats Trimestriels Approbation Réglementaire Expansion Du Marché Test De Dépistage De La Syphilis Données Financières De MedMira
BRIEF published on 06/30/2026 at 02:05, 27 days 18 hours ago MedMira's Q3 FY2026 Financial Review and Market Expansion Efforts Regulatory Approval Market Expansion Quarterly Results Syphilis Test MedMira Financials
PRESS RELEASE published on 06/30/2026 at 02:00, 27 days 18 hours ago MedMira Reports Third Quarter Results FY2026 MedMira Inc. (TSXV:MIR) reports on Q3 FY2026 financial results, advances regulatory process for Multiplo® Complete Syphilis Antibody Test, and increases international market interest Financial Results Regulatory Approval MedMira Inc. International Markets Rapid Diagnostic Tests
BRIEF published on 04/02/2026 at 04:05, 3 months 25 days ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
BRIEF published on 04/02/2026 at 04:05, 3 months 25 days ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
PRESS RELEASE published on 04/02/2026 at 04:00, 3 months 25 days ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 6 months 27 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 6 months 27 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 6 months 27 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 7 months 28 days ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
Published on 07/27/2026 at 14:00, 6 hours 48 minutes ago Silver Storm Announces First Concentrate Shipment from La Parrilla
Published on 07/27/2026 at 13:30, 7 hours 18 minutes ago International Battery Metals Announces CEO Transition
Published on 07/27/2026 at 13:30, 7 hours 18 minutes ago Strategic Metals Options Yukon Copper-Gold Projects to GGL Resources Corp.
Published on 07/27/2026 at 13:30, 7 hours 18 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares; Closing Expected in October 2026
Published on 07/27/2026 at 13:30, 7 hours 18 minutes ago Reeflex Announces Updated Investor Presentation and Upcoming Investor Conference Participation
Published on 07/27/2026 at 19:42, 1 hour 5 minutes ago EQS-Adhoc: Lenzing AG: Lenzing AG advances strategic transformation
Published on 07/27/2026 at 19:00, 1 hour 47 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 20 JUILLET 2026 au 24 JUILLET 2026
Published on 07/27/2026 at 18:00, 2 hours 47 minutes ago Saint-Gobain accélère en Asie avec deux acquisitions ciblées
Published on 07/27/2026 at 18:00, 2 hours 47 minutes ago Saint-Gobain accelerates in Asia with two targeted acquisitions
